Drug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growth. The Mumbai-based drug maker is also bullish on maximising value opportunity in the complex generics in the
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/InSBZhW
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/InSBZhW